Differential effects of HIF2α antagonist and HIF2α silencing in renal cancer and sensitivity to repurposed drugs by Arnaiz, E, Miar, A, Bridges, E, Prasad, N, Hatch, SB, Ebner, D, Lawrie, CH, Harris, AL

MicroRNAs as B-cell lymphoma biomarkers by Manterola L, Fernandez-Mercado M, Larrea E, Goicoechea I, Arestin M, Armesto M, Hernandez L, Lawrie CH

Get full text

Identification of miRNAs and Their Target Genes Associated with Sunitinib Resistance in Clear Cell Renal Cell Carcinoma Patients by Armesto, M, Nemours, S, Arestín, M, Bernal, I, Solano-Iturri, JD, Manrique, M, Basterretxea, L, Larrinaga, G, Angulo, JC, Lecumberri, D, Iturregui, AM, López, JI, Lawrie, CH

DNMT1 is predictive of survival and associated with Ki-67 expression in R-CHOP-treated diffuse large B-cell lymphomas by Loo, SK, Ch'ng, ES, Lawrie, CH, Muruzabal, MA, Gaafar, A, Pomposo, MP, Husin, A, Salleh, MS, Banham, AH, Pedersen, LM, Møller, MB, Green, TM, Wong, KK